23andMe Holding Company (ME) Quote

Independent Directors of 23andMe Resign from Board
September 17 2024 - 4:26PM


The independent directors of the Board of 23andMe Holding Co. (Nasdaq: ME), today sent the following letter to Anne Wojcicki, Chief Executive Officer, Co-Founder, and Chair of the Board of Directors of 23andMe, in which the independent directors have provided their resignation from the Board, effective immediately:

Dear Anne,

We, the independent directors of the 23andMe Board, hereby tender our resignations, effective immediately.

After months of work, we have yet to receive from you a fully financed, fully diligenced, actionable proposal that is in the best interests of the non-affiliated shareholders. We believe the Special Committee and the Board have provided ample time for you to submit such a proposal. That we have not seen any notable progress over the last 5 months leads us to believe no such proposal is forthcoming. The Special Committee is therefore unwilling to consider further extensions, and the Board agrees with the Special Committee’s determination.

While we continue to wholeheartedly support the Company’s mission and believe deeply in the value of the personalized health and wellness offering that you have articulated, it is also clear that we differ on the strategic direction for the Company going forward. Because of that difference and because of your concentrated voting power, we believe that it is in the best interests of the Company’s shareholders that we resign from the Board rather than have a protracted and distracting difference of view with you as to the direction of the Company.

We are proud of what 23andMe has achieved in pioneering direct access to genetic information, and we have been honored to have had the opportunity to be part of those efforts.

Sincerely,

/s/

Roelof Botha, Patrick Chung, Sandra Hernández, M.D., Neal Mohan, Valerie Montgomery Rice M.D., Richard Scheller, Ph.D., Peter J. Taylor

About 23andMe

23andMe is a genetics-led consumer healthcare and biopharmaceutical company empowering a healthier future. For more information, please visit www.23andMe.com.

..coulda woulda shoulda, run into the ground..too bad ...

IS THIS STOCK A SCAM OR WHAT??? I WHAT THE TRUTH!!!

FOXO EPIGENETICS AI LOW FLOATER IS THE KEYS TO AI

ME new 52 low

ME new 52 low

Data on the dark web no less, useless ...

Not great, but that's part of the game friend. Sometimes you lose.

..only $170M market cap, sell to highest bidder! ME$$,,,

AI, law enforcement/gov, pharma want ME dna database imo...

Corporate theft IMO. The CEO and her board of minions should be excluded from any voting on this.

Let insiders take private?, voting NO here...

How'd that work out?

It doesn’t bother me, since I have lots of money to buy shares of a company like Curtis-Wright

Kathy Hibbs is selling about 35K shares per week but it should slow down since the price is now lower than what she gets them for. 42 cents

She only has like 115K left before they reload to feed themselves more shares

ME new 52 lo

Didn't like it in the .60 and see even less to like at .44 -

I have only one question - Will it be a quick BK or a slow drawn out worthless attempt to infuse some sort of actual value?

ME new 52 week low

Hey I'm a gambler but I'm not willing to put any money into this. The Q reads like a failing business venture to me. I saw absolutely no bright spots in the filing. It was worth a look to save my funds from devastating losses.

Grabbed a butt load at .8

https://www.otcmarkets.com/stock/ME

https://www.otcmarkets.com/stock/ME

https://www.otcmarkets.com/stock/ME

Buyside bias last 5 sessions. Will pop

ME new 52 week low

ME new 52 week low

https://www.otcmarkets.com/stock/ME

ME new 52 week low

ME new 52 week low

23andMe Granted New FDA Clearance to Report Additional BRCA Variants

Hammer bottom

ME new 52 Week low

ME new 52 week low

ME
23andMe Holding Company
1.51
-0.015 (-0.98%)
Volume: 2,773,867
Day Range: 1.45 - 1.53
Last Trade Time: 7:59:42 PM EDT

ME new 52 week low

23andMe Holding Co. NASDAQ: ME

GoSymbol lookup
Health Care : Health Care Providers & Services | Small Cap BlendCompany profile
23andMe Holding Co. is a genetics-led consumer healthcare and therapeutics company. The Company operates through two segments: Consumer & Research Services and Therapeutics. The Consumer & Research Services business segment comprises its Personal Genome Service (PGS), telehealth business, and research service. PGS services provide customers with a broad suite of genetic reports, including information on customers’ genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. The Therapeutics business segment focuses on the use of genetic insights from databases of genetic and phenotypic information to develop novel therapies to improve patients’ lives. The Therapeutics segment consists of out-licensing of intellectual property associated with identified drug targets and expenses related to therapeutic product candidates.

Great news today, anyone else excited by that green hammer at the close? Let's rock on Monday!

ME
23andMe Holding Company
1.67
0.04 (2.45%)
Volume: 1,009,450
Day Range: 1.64 - 1.71
Last Trade Time: 7:59:13 PM EDT

ME
23andMe Holding Company
1.64
0.05 (3.14%)
Volume: 7,698,993
Day Range: 1.57 - 1.65
Last Trade Time: 7:58:30 PM EDT

ME
23andMe Holding Company
2.07
0.03 (1.47%)
Volume: 4,213,342
Day Range: 1.8338 - 2.10
Last Trade Time: 7:59:16 PM EDT

ME
23andMe Holding Company
1.99
0.11 (5.85%)
Volume: 1,349,148
Day Range: 1.825 - 1.99
Last Trade Time: 7:36:16 PM EDT

Have 12k shares here now. The data here is extremely valuable.

ME
23andMe Holding Company
2.25
-0.04 (-1.75%)
Volume: 948,040
Day Range: 2.19 - 2.30
Last Trade Time: 7:56:39 PM EDT

ME
23andMe Holding Company
2.25
-0.04 (-1.75%)
Volume: 948,040
Day Range: 2.19 - 2.30
Last Trade Time: 7:56:39 PM EDT

ME
23andMe Holding Company
2.51
-0.08 (-3.09%)
Volume: 1,419,788
Day Range: 2.48 - 2.57
Last Trade Time: 7:24:32 PM EST

ME
23andMe Holding Company
2.59
-0.28 (-9.76%)
Volume: 3,437,659
Day Range: 2.49 - 2.68
Last Trade Time: 6:25:22 PM EST

ME
23andMe Holding Company
2.59
-0.28 (-9.76%)
Volume: 3,437,659
Day Range: 2.49 - 2.68
Last Trade Time: 6:25:22 PM EST

ME
23andMe Holding Company
2.68
-0.07 (-2.55%)
Volume: 2,344,468
Day Range: 2.64 - 2.80
Last Trade Time: 7:32:55 PM EST

ME
23andMe Holding Company
2.64
-0.05 (-1.86%)
Volume: 7,648,803
Day Range: 2.54 - 2.68
Last Trade Time: 7:58:03 PM EST

ME
23andMe Holding Company
2.8799
-0.0201 (-0.69%)
Volume: 2,373,575
Day Range: 2.78 - 2.92
Bid: 2.38
Ask: 3.37
Last Trade Time: 7:52:48 PM EDT
Total Trades: 12,726
ME Detailed Quote